Nine Chapters Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-1,900
Closed -$536K – 1186
2015
Q1
$536K Sell
1,900
-3,800
-67% -$823K 0.05% 581
2014
Q4
$889K Buy
5,700
+3,600
+171% +$665K 0.08% 365
2014
Q3
$497K Buy
+2,100
New +$535K 0.04% 516

Other funds holding ICPT

Nine Chapters Capital Management's ICPT Position: Q2 2015 in Review

Nine Chapters Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2015, closing a stake of 1,900 shares — an estimated $536K sold.

Nine Chapters Capital Management first reported a position in ICPT in Q3 2014 and held it in 3 quarters. The position peaked at $889K in Q4 2014. 191 funds tracked by Wall St. Rank hold ICPT as of Q2 2015.

  • Nine Chapters Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 1,900 Intercept Pharmaceuticals, Inc. shares in Q2 2015, an estimated $536K.
  • Nine Chapters Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 3 quarters.
  • Nine Chapters Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $889K in Q4 2014.
  • 191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2015.

Based on Nine Chapters Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.